NEW YORK (GenomeWeb) – Multiple copies of the tumor suppressor gene TP53 appear to play a role in lower rates of cancer development in elephants, according to a new study led by Joshua Schiffman of the University of Utah School of Medicine.

The results, published today in the Journal  of the American Medical Association, may also have potential to provide a better understanding of the suppression (or promotion) of cancer in humans, according to Schiffman and his colleagues.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.